NCT03516617 2026-02-09Acalabrutinib With or Without Obinutuzumab in Treating Patients With Early-Stage Chronic Lymphocytic Leukemia or Small Lymphocytic LymphomaMayo ClinicPhase 2 Recruiting120 enrolled
NCT00093470 2024-03-20Tipifarnib in Treating Patients With Acute Myeloid Leukemia in RemissionNational Cancer Institute (NCI)Phase 3 Completed144 enrolled 8 charts